Capital World Investors Astrazeneca PLC Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital World Investors holds 6,254,682 shares of AZN stock, worth $419 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,254,682

Previous 6,252,339 0.04%

Holding current value

$419 Million

Previous $488 Million 0.05%

% of portfolio

0.08%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $179,637 - $205,293	2,343 Added 0.04%	6,254,682 $487 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $208 Million - $252 Million	-3,113,337 Reduced 33.24%	6,252,339 $488 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $1.8 Million - $2.05 Million	29,497 Added 0.32%	9,365,676 $635 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $25,808 - $28,889	417 Added 0.0%	9,336,179 $629 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $12.3 Million - $13.6 Million	189,758 Added 2.07%	9,335,762 $632 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $56.6 Million - $61.4 Million	809,779 Added 9.71%	9,146,004 $655 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $69.6 Million - $78.9 Million	1,102,304 Added 15.24%	8,336,225 $579 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $206 Million - $267 Million	3,797,067 Added 110.48%	7,233,921 $490 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $63.6 Million - $163 Million	1,200,183 Added 53.66%	3,436,854 $188 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $175 Million - $210 Million	-2,949,813 Reduced 56.88%	2,236,671 $148 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $518,251 - $624,283	-9,301 Reduced 0.18%	5,186,484 $344 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $897,758 - $1.06 Million	16,619 Added 0.32%	5,195,785 $303 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $11.9 Million - $13 Million	214,424 Added 4.32%	5,179,166 $311 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $15.4 Million - $19.1 Million	317,944 Added 6.84%	4,964,742 $297 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $804,125 - $928,256	17,051 Added 0.37%	4,646,798 $231 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $43.1 Million - $51.5 Million	-887,832 Reduced 16.09%	4,629,747 $231 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $407,153 - $468,759	7,672 Added 0.14%	5,517,579 $302 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $1.15 Million - $1.48 Million	26,671 Added 0.49%	5,509,907 $291 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $58.3 Million - $79.2 Million	1,543,667 Added 39.18%	5,483,236 $245 Million
Q4 2019 Feb 18, 2020	SELL	$42.46 - $50.46 $249 Million - $296 Million	-5,875,650 Reduced 59.86%	3,939,569 $196 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $21.9 Million - $24.8 Million	544,959 Added 5.88%	9,815,219 $437 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $29.6 Million - $33.1 Million	795,239 Added 9.38%	9,270,260 $383 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $87.8 Million - $106 Million	2,474,997 Added 41.25%	8,475,021 $343 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $37.1 Million - $41.8 Million	-1,006,528 Reduced 14.37%	6,000,024 $228 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $278 - $317	8 Added 0.0%	7,006,552 $277 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $83.3 Million - $92.6 Million	2,527,960 Added 56.45%	7,006,544 $245 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $128 - $139	4 Added 0.0%	4,478,584 $155 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $130 Million - $152 Million	4,478,580	4,478,580 $152 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Astrazeneca PLC Transaction History